Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sherman

Showing results (751-760 of 825) with videos related to

Pageof 83
Sort By:
Thyroid : Official Journal of the American Thyroid Association|August 15, 2018
Intensity-Modulated Radiation Therapy With or Without Concurrent Chemotherapy in Nonanaplastic Thyroid Cancer with Unresectable or Gross Residual DiseaseThomas H Beckham, Paul B Romesser, Andries H Groen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2014
Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC)M G Fury, E J Sherman, S S Rao, et al.
Cancer|October 9, 2019
Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancerDan Fan, Jennifer Ma, Andrew C Bell, et al.
Molecular Cancer Research : MCR|October 12, 2021
Genomic and Transcriptomic Correlates of Thyroid Carcinoma Evolution after BRAF Inhibitor TherapyMark Lee, Brian R Untch, Bin Xu, et al.
Cancer|July 22, 2021
Intensity-modulated radiation therapy and doxorubicin in thyroid cancer: A prospective phase 2 trialPaul B Romesser, Eric J Sherman, Karissa Whiting, et al.
Journal of General Internal Medicine|May 24, 2018
Effect of Low Back Pain Risk-Stratification Strategy on Patient Outcomes and Care Processes: the MATCH Randomized Trial in Primary CareDan Cherkin, Benjamin Balderson, Rob Wellman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2021
Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid CancerLori J Wirth, Marcia S Brose, Eric J Sherman, et al.
Journal of Neuro-Oncology|October 14, 2025
Rapid early progression of glioblastoma: evaluation of a novel prognostic radiologic biomarkerJacob Guzzino, David J Crompton, Shubhi Agarwal, et al.
JAMA Network Open|June 18, 2021
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation TherapyXingzhe Li, Sarin Kitpanit, Anna Lee, et al.
Endocrine-Related Cancer|April 23, 2021
Co-inhibition of SMAD and MAPK signaling enhances 124I uptake in BRAF-mutant thyroid cancersKathleen A Luckett, Jennifer R Cracchiolo, Gnana P Krishnamoorthy, et al.
Pageof 83

Showing results (751-760 of 825) with videos related to

Sort By:
Pageof 83
Thyroid : Official Journal of the American Thyroid Association|August 15, 2018
Intensity-Modulated Radiation Therapy With or Without Concurrent Chemotherapy in Nonanaplastic Thyroid Cancer with Unresectable or Gross Residual DiseaseThomas H Beckham, Paul B Romesser, Andries H Groen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2014
Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC)M G Fury, E J Sherman, S S Rao, et al.
Cancer|October 9, 2019
Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancerDan Fan, Jennifer Ma, Andrew C Bell, et al.
Molecular Cancer Research : MCR|October 12, 2021
Genomic and Transcriptomic Correlates of Thyroid Carcinoma Evolution after BRAF Inhibitor TherapyMark Lee, Brian R Untch, Bin Xu, et al.
Cancer|July 22, 2021
Intensity-modulated radiation therapy and doxorubicin in thyroid cancer: A prospective phase 2 trialPaul B Romesser, Eric J Sherman, Karissa Whiting, et al.
Journal of General Internal Medicine|May 24, 2018
Effect of Low Back Pain Risk-Stratification Strategy on Patient Outcomes and Care Processes: the MATCH Randomized Trial in Primary CareDan Cherkin, Benjamin Balderson, Rob Wellman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2021
Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid CancerLori J Wirth, Marcia S Brose, Eric J Sherman, et al.
Journal of Neuro-Oncology|October 14, 2025
Rapid early progression of glioblastoma: evaluation of a novel prognostic radiologic biomarkerJacob Guzzino, David J Crompton, Shubhi Agarwal, et al.
JAMA Network Open|June 18, 2021
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation TherapyXingzhe Li, Sarin Kitpanit, Anna Lee, et al.
Endocrine-Related Cancer|April 23, 2021
Co-inhibition of SMAD and MAPK signaling enhances 124I uptake in BRAF-mutant thyroid cancersKathleen A Luckett, Jennifer R Cracchiolo, Gnana P Krishnamoorthy, et al.
Pageof 83